company background image
GOVX

GeoVax Labs NasdaqCM:GOVX Stock Report

Last Price

US$0.79

Market Cap

US$20.8m

7D

0.2%

1Y

-83.2%

Updated

27 Nov, 2022

Data

Company Financials +
GOVX fundamental analysis
Snowflake Score
Valuation4/6
Future Growth2/6
Past Performance0/6
Financial Health5/6
Dividends0/6

GOVX Stock Overview

GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ankara virus-like particle vaccine platform.

GeoVax Labs, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for GeoVax Labs
Historical stock prices
Current Share PriceUS$0.79
52 Week HighUS$4.58
52 Week LowUS$0.55
Beta2.94
1 Month Change-19.23%
3 Month Change-34.26%
1 Year Change-83.18%
3 Year Change-96.97%
5 Year Change-100.00%
Change since IPO-100.00%

Recent News & Updates

We Think GeoVax Labs (NASDAQ:GOVX) Needs To Drive Business Growth Carefully

Sep 08
We Think GeoVax Labs (NASDAQ:GOVX) Needs To Drive Business Growth Carefully

Recent updates

We Think GeoVax Labs (NASDAQ:GOVX) Needs To Drive Business Growth Carefully

Sep 08
We Think GeoVax Labs (NASDAQ:GOVX) Needs To Drive Business Growth Carefully

Companies Like GeoVax Labs (NASDAQ:GOVX) Could Be Quite Risky

May 24
Companies Like GeoVax Labs (NASDAQ:GOVX) Could Be Quite Risky

We Think GeoVax Labs (NASDAQ:GOVX) Can Afford To Drive Business Growth

Nov 27
We Think GeoVax Labs (NASDAQ:GOVX) Can Afford To Drive Business Growth

We Think GeoVax Labs (NASDAQ:GOVX) Can Afford To Drive Business Growth

Aug 14
We Think GeoVax Labs (NASDAQ:GOVX) Can Afford To Drive Business Growth

Did Business Growth Power GeoVax Labs' (NASDAQ:GOVX) Share Price Gain of 111%?

Feb 18
Did Business Growth Power GeoVax Labs' (NASDAQ:GOVX) Share Price Gain of 111%?

Shareholder Returns

GOVXUS BiotechsUS Market
7D0.2%0.4%1.3%
1Y-83.2%-14.4%-18.5%

Return vs Industry: GOVX underperformed the US Biotechs industry which returned -14.4% over the past year.

Return vs Market: GOVX underperformed the US Market which returned -18.5% over the past year.

Price Volatility

Is GOVX's price volatile compared to industry and market?
GOVX volatility
GOVX Average Weekly Movement21.7%
Biotechs Industry Average Movement11.1%
Market Average Movement7.4%
10% most volatile stocks in US Market15.6%
10% least volatile stocks in US Market3.3%

Stable Share Price: GOVX is more volatile than 90% of US stocks over the past 3 months, typically moving +/- 22% a week.

Volatility Over Time: GOVX's weekly volatility has decreased from 33% to 22% over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
198811David Doddhttps://www.geovax.com

GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections, and solid tumor cancers. The company has collaboration and partnership agreements with the National Institute of Allergy and Infectious Diseases of the National Institutes of Health; Centers for Disease Control and Prevention; U.S.

GeoVax Labs, Inc. Fundamentals Summary

How do GeoVax Labs's earnings and revenue compare to its market cap?
GOVX fundamental statistics
Market CapUS$20.78m
Earnings (TTM)-US$22.38m
Revenue (TTM)US$246.49k

84.4x

P/S Ratio

-0.9x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
GOVX income statement (TTM)
RevenueUS$246.49k
Cost of RevenueUS$18.25m
Gross Profit-US$18.01m
Other ExpensesUS$4.37m
Earnings-US$22.38m

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.85
Gross Margin-7,305.27%
Net Profit Margin-9,079.68%
Debt/Equity Ratio0.0%

How did GOVX perform over the long term?

See historical performance and comparison